Leadership Overview
Norstella has 6 executives leading key functions including strategy, finance, technology, revenue, and operations.
Driven by a commitment to patient access, Norstella unites market-leading companies to deliver critical answers for strategic and commercial decision-making, navigating complexities across the drug development lifecycle with advanced data solutions and expert advisory services.
Driven by a commitment to patient access, Norstella unites market-leading companies to deliver critical answers for strategic and commercial decision-making, navigating complexities across the drug development lifecycle with advanced data solutions and expert advisory services.
Leadership Roles at Norstella
Michael Gallup - Chief Executive Officer
Michael Gallup, the Chief Executive Officer at Norstella, directs the overarching corporate strategy and operational execution. Gallup guides the integration of Norstella's distinct organizations—Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group—to foster a unified approach to improving patient access within the life sciences sector. This leadership involves aligning diverse teams and capabilities to deliver essential intelligence for critical strategic and commercial decisions. Gallup ensures the company leverages its leading scarce data assets to support clients throughout the entire drug development life cycle, from pipeline identification to patient delivery. The Chief Executive Officer's focus remains on enhancing the breadth of expertise, cutting-edge data solutions, and expert advisory services offered, integrating advanced technologies like real-world data, machine learning, and predictive analytics. Michael Gallup's strategic vision propels Norstella's mission to help life sciences clients navigate industry complexities and achieve significant market impact.
Michael Doherty - Chief of Staff To the Chief Executive Officer
Michael Doherty, the Chief of Staff To the Chief Executive Officer at Norstella, provides strategic support and operational coordination to Michael Gallup. Doherty facilitates the execution of key initiatives and ensures seamless communication across Norstella's integrated companies, including Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group. This role involves managing critical projects, driving cross-functional alignment, and optimizing operational efficiency to support the company's mission of improving patient access. The Chief of Staff To the Chief Executive Officer acts as a key liaison, translating strategic priorities into actionable plans and monitoring progress against organizational goals. Doherty's responsibilities include enhancing the synergy between different business units, ensuring that advanced technologies and data solutions are effectively deployed to meet client needs throughout the drug development life cycle. Michael Doherty's support is vital for the effective implementation of Norstella's strategic vision and operational excellence.
Daniel Tempesta - Chief Financial Officer
Daniel Tempesta, the Chief Financial Officer at Norstella, oversees all financial operations and strategic fiscal planning. Tempesta manages the financial health and resource allocation across Norstella's integrated entities, ensuring robust fiscal discipline and driving profitable growth. This role involves developing financial models, managing investments, and optimizing capital structure to support the company's mission of improving patient access. The Chief Financial Officer analyzes market trends and financial performance to inform strategic decision-making, particularly concerning the acquisition and integration of data assets and advanced technologies. Tempesta's oversight extends to financial reporting, compliance, and risk management, safeguarding the company's assets and ensuring long-term financial stability. By providing critical financial insights, Daniel Tempesta enables Norstella to effectively navigate the complexities of the drug development life cycle and deliver enhanced value to its life sciences clients.
Andrew Augustine - Chief Technology Officer
Andrew Augustine, the Chief Technology Officer at Norstella, architects and directs the company's technological infrastructure and innovation roadmap. Augustine leads the integration and advancement of cutting-edge technologies, including real-world data, machine learning, and predictive analytics, across Norstella's diverse portfolio of solutions. This involves ensuring the scalability, security, and efficiency of the technology platforms that underpin critical strategic and commercial decision-making for life sciences clients. The Chief Technology Officer collaborates closely with other executive leaders to translate business objectives into robust technological strategies, enhancing the company's data assets and analytical capabilities. Augustine's purview includes overseeing the development of new data solutions and optimizing existing systems to support clients throughout the drug development life cycle. Andrew Augustine's technical leadership is pivotal in maintaining Norstella's position as a leading pharma intelligence solutions provider.
Kevin D'Ambrosia - Chief Revenue Officer, Heorand Rwe & Rwd & Skipta
Kevin D'Ambrosia, the Chief Revenue Officer, Heorand Rwe & Rwd & Skipta at Norstella, drives revenue generation and commercial strategy for key business units. D'Ambrosia focuses on expanding market penetration and maximizing revenue streams within the Health Economics and Outcomes Research (HEOR), Real-World Evidence (RWE), Real-World Data (RWD), and Skipta platforms. This leadership role involves developing and executing sales strategies, fostering client relationships, and ensuring alignment between commercial efforts and product development. The Chief Revenue Officer works to enhance the value proposition of Norstella's data solutions and advisory services, particularly for clients navigating the complexities of drug development and market access. D'Ambrosia's efforts are critical in translating Norstella's technological capabilities and data assets into tangible commercial success and improved patient access outcomes. Kevin D'Ambrosia's commercial acumen is essential for driving growth across these specialized segments.
Joel Keefe - Chief Revenue Officer, Mmit, Skipta, Panalgo, Rwd & Evidence Generation
Joel Keefe, the Chief Revenue Officer, Mmit, Skipta, Panalgo, Rwd & Evidence Generation at Norstella, spearheads revenue growth and commercial strategy for critical business units. Keefe directs sales efforts and market development for MMIT, Skipta, Panalgo, and the Real-World Data (RWD) & Evidence Generation functions, focusing on enhancing client value and expanding market reach. This leadership involves forging strategic partnerships and optimizing commercial operations to ensure Norstella's solutions effectively address the evolving needs of life sciences clients. The Chief Revenue Officer works to integrate diverse data assets and advanced technologies, such as machine learning and predictive analytics, to drive commercial success and improve patient access. Keefe's focus on evidence generation and market intelligence is crucial for clients navigating the complexities of drug development and commercialization. Joel Keefe's commercial leadership is instrumental in driving revenue and market impact across these vital segments of Norstella's business.
Explore Leadership Teams in Business Services
Founded in 2000 and headquartered in Hsinchu City, Taiwan, Star Technologies provides intellectual property, software, hardware, consumables, service and expertise to meet the requirements and challenges within the semiconductor industries. The company has subsidiaries in the US, Japan, South Korea, Singapore, China and India.
Company Leadership PJ
Founded in 2010 and headquartered in St. Louis, Missouri, TierPoint provides IT and data center services. They offer customers cloud-to-cloud recovery, backup services, encryption services, managed hosting, internet bandwidth, and more.
Company Leadership GS
TekSynap understands both the pace of technology today and the need to have a comprehensive well planned information management environment. Technology moving at the speed of thought® embodies these principles the need to nimbly utilize the best that information technology offers to meet the business needs of their Federal Government customers. The TekSynap founders have worked together for over a decade, supporting customers ranging from small departmental operations & maintenance efforts to leading broad nationwide deployment efforts for agencies such as the U.S. Department of Veterans Affairs. This core management team has operated in leading companies such as SIGNAL Corporation and managed business sectors of over 100M in annual revenue in industry leading companies such as General Dynamics. At each level this team has absorbed what works for the company, our customers and our employees. We synthesize the best at each level resulting in a unique service provider that combines the infrastructure and process models of larger organizations with an agile ability to cost effectively meet our customers requirements.
Company Leadership KJ
LN
Sentinel Technologies is a business technology services provider that specializes in IT solutions, customer service, and support. The company was founded in 1982 and is headquartered in Downers Grove, Illinois.
Company Leadership TH
Frequently Asked Questions Regarding Norstella Top Executives and Leadership Team
